ADIAL PHARMACEUTICALS, INC.

Lobbying client · Virginia · filed 2025 to 2026

Pharmaceutical company

$60,000 Reported spend

6 Filings counted

1 Firms hired

2 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (63722), not by name.

Firms hired 1

RK STRATEGIES, INC. $60,000 6 filings

Bills named in these filings 2

HR 7091
Expanding Veterans’ Access to Emerging Treatments Act

2 filings
HR 8800
National Defense Authorization Act for Fiscal Year 2027

1 filing

Reported by year 2 years

2026 $20,000 2 filings
2025 $40,000 4 filings

Issues lobbied 2

Health Issues 6
Defense 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 3

Food & Drug Administration (FDA) 6
HOUSE OF REPRESENTATIVES 6
SENATE 6

Recent filings 6 total

2T

RK STRATEGIES, INC.

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $10,000 income · posted Jul 18, 2026

View → Q1

RK STRATEGIES, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $10,000 income · posted Apr 20, 2026

View → Q4

RK STRATEGIES, INC.

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $10,000 income · posted Jan 20, 2026

View → Q3

RK STRATEGIES, INC.

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $10,000 income · posted Oct 20, 2025

View → Q2

RK STRATEGIES, INC.

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $10,000 income · posted Jul 21, 2025

View → Q1

RK STRATEGIES, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $10,000 income · posted Apr 21, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.